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Commentary 
A comment on: ‘Molecular diagnosis of transthyretin Met30 mutation 
in an Italian family with familial amyloidotic polyneuropathy’ 
by Paola Strocchi et al., FEBS Letters 359 (1995) 203-205 
G. Di Iorio, G. Sanges, S. Sampaolo, V. Bonavita 
Institute of Neurological Sciences, Second University of Naples, Via Pansini, 5, 80131 Naples, Italy 
Familial amyloidotic polyneuropathy (FAP) is a heteroge- 
neous group of genetic disorders characterized by progressive 
systemic deposition of extracellular amyloid fibrils, mainly 
affecting the peripheral nervous system. These disorders, in- 
herited as an autosomal dominant trait, have frequently been 
described in various ethnic groups, but have rarely been re- 
ported in Italy. 
In 1993, we published (Italian Journal of Neurological 
Sciences 14 (1993) 303-309) a new Italian FAP kindred in- 
cluding 106 members over six generations, with 19 proven 
affected individuals. Genomic DNA analysis of the preposi- 
tus, performed by Alessandro Mauro from the University of 
Turin, revealed a TTR 30Val-Met substitution. This family 
was included in a clinical follow-up and in a molecular and 
genetic study, as already heralded in our article. The data will 
be soon published in a new paper. 
Dr. Strocchi, to whom we simply sent some blood samples 
for amino acid sequencing of the amyloidogenic protein, used 
the whole of the clinical and laboratory data of the members 
of this family for the drawing up of her article, taking the data 
from our article without any verbal or written request for 
their use. 
The behaviour of Dr. Strocchi is difficult to justify. 
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